Correlation Between Legend Biotech and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Legend Biotech and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and Biomarin Pharmaceutical.
Diversification Opportunities for Legend Biotech and Biomarin Pharmaceutical
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Legend and Biomarin is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Legend Biotech i.e., Legend Biotech and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Legend Biotech and Biomarin Pharmaceutical
Given the investment horizon of 90 days Legend Biotech Corp is expected to generate 1.69 times more return on investment than Biomarin Pharmaceutical. However, Legend Biotech is 1.69 times more volatile than Biomarin Pharmaceutical. It trades about -0.17 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.29 per unit of risk. If you would invest 4,395 in Legend Biotech Corp on August 24, 2024 and sell it today you would lose (420.00) from holding Legend Biotech Corp or give up 9.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Legend Biotech Corp vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Legend Biotech Corp |
| Biomarin Pharmaceutical |
Legend Biotech and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Legend Biotech and Biomarin Pharmaceutical
The main advantage of trading using opposite Legend Biotech and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Legend Biotech vs. ZyVersa Therapeutics | Legend Biotech vs. Sonnet Biotherapeutics Holdings | Legend Biotech vs. Zura Bio Limited | Legend Biotech vs. Phio Pharmaceuticals Corp |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |